Dr Cohen joins Kosan from GE Healthcare Medical Diagnostics where she served as the global oncology therapeutic area head, responsible for strategic development, clinical trial implementation and registration of the GE Healthcare-Medical Diagnostics Division’s product portfolio of molecularly targeted imaging diagnostics.
Dr Cohen received her undergraduate degree from Barnard College, Columbia University and her medical degree from the Mount Sinai School of Medicine.
Helen Kim, Kosan’s president and CEO, said: “Recruiting an experienced and accomplished chief medical officer was one of Kosan’s major goals for 2008. We are delighted that Pam will be able to leverage her direct knowledge of cytotoxic and targeted oncology drug development to bring leadership, direction and focus to the execution of Kosan’s development activities.”